The central mechanism of hypothalamic-pituitary-adrenocortical system hyperfunction in depressed patients

Psychiatry and Clinical Neurosciences

Volumn 54, Issue 2, 2000, Pages 227-234

  Jiang, Hann Kuang ^a   Wang, Jia Yi ^a   Lin, Jiann Chyun ^b  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Hypercortisolemia; Hypothalamic pituitary adrenocortical function; Major depression

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE;

ADRENAL CORTEX; ADULT; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; BRAIN FUNCTION; CLINICAL ARTICLE; DEPRESSION; FEMALE; HORMONE RESPONSE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERCORTISOLISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MENTAL PATIENT; NEUROENDOCRINE SYSTEM;

ADOLESCENT; ADRENAL CORTEX; ADRENOCORTICAL HYPERFUNCTION; ADRENOCORTICOTROPIC HORMONE; ADULT; COSYNTROPIN; DEPRESSIVE DISORDER, MAJOR; DEXAMETHASONE; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; REFERENCE VALUES;

EID: 0034056361     PISSN: 13231316     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1819.2000.00663.x     Document Type: Article

References (36)

1. Clark LD, Quarton QC, Cobb S, Bauer W. Further observation on mental disturbances associated with cortisol and ACTH therapy. N. Engl. J. Med. 1953; 249: 178-183.
2. DeWied D. Pituitary-adrenal system hormones and behavior. In: Schmitt PO, Worden FG (eds). The Neurosciences: Third Study Program. MIT Press, Cambridge, 1974; 653-666.
3. Carroll BJ. Neuroendocrine function in psychiatric disorders. In: DiMascio MA, Killam KF (eds). Psychopharmacology: A Generation of Progress. Raven Press, Cambridge, 1978; 487-506.
4. Kathol RG, Jaeckle RS, Lopez JF, Meller WH. Pathophysiology of HPA axis abnormalities in patients with major depression: An update. Am. J. Psychiatry 1989; 146: 311-317.
5. Carroll BJ, Mendels J. Neuroendocrine regulation in affective disorders. In: Sachar EJ (ed.). Hormone, Behavior, and Psychopathology. Raven Press, New York, 1976; 193-224.
6. Sachar EJ. Twenty-four-hour cortisol secretory patterns in depressed and manic patients. In: Gispen WH, Greidanus BVW, Deweid BB (eds). Hormones, Homeostasis and the Brain Research, Vol. 42. Elsevier, Amsterdam, 1975; 81-91.
7. Rubin RT, Poland RE, Lesser IM, Winston RA, Blodgett ALN. Neuroendocrine aspects of primary endogenous depression: I. Cortisol secretory dynamics in patients and matched controls. Arch. Gen. Psychiatry 1987; 44: 328-336.
8. Carroll BJ, Curtis BM, Davies JM, Mendels J, Sugerman AA. Urinary free cortical excretion in depression. Psychol. Med. 1976; 6: 45-59.
9. Endo M, Endo J, Niskikubo T, Yamaguchi T, Hatotani N. Endocrine studies in depression. In: Hatotani N (ed.). Psychoneuroendocrinology. Karger, Basel, 1976; 22-31.
10. Fang VS, Tricou A, Robertson A, Meltzer HY. Plasma ACTH and cortisol levels in depressed patients: Relation to dexamethasone test. Life Sci. 1981; 29: 931-938.
11. Yerevanian BI, Woolf PD. Plasma ACTH levels in primary depression: Relationship to the 24-hour dexamethasone suppression test. Psychiatry Res. 1983; 9: 45-51.
12. Linkowski P, Mendlewicz J, Leclercq R et al. The 24-hour profile of adrenocorticotropin and cortisol in major depressive illness. J. Clin. Endocrinol. Meta. 1985; 61: 429-438.
13. Galard R, Gallart JM, Catalan R, Schwartz S, Greden JF. Salivary cortisol levels and their correlation with plasma ACTH levels in depressed patients before and after the DST. Am. J. Psychiatry 1991; 148: 505-508.
14. Carpenter WT, Bunney WE. Adrenal cortical activity in depressive illness. Am. J. Psychiatry 1971; 18: 31-40.
15. Amsterdam JA, Winokur E, Abelman IL, Lucki I, Rickels K. Cosyntropin (ACTH1-24) stimulation test in depressed patients and healthy subjects. Am. J. Psychiatry 1983; 140: 907-909.
16. Holsboer F, Muller OA, Doerr HG et al. ACTH and multisteroid responses to corticotropin-releasing factor after ACTH stimulation and dexamethasone suppression. Psychoneuroendocrinol. 1984; 9: 147-160.
17. 1-24) stimulation in major depression: Relationship to dexamethasone suppression test results. Arch. Gen. Psychiatry 1987; 44: 233-240.
18. Fang VS, Jiang HK, Lu RB, Rose RP, Luchins DJ. Cortisol response to ACTH infusion in depressed patients: Comparison with age-, sex-, and weight-matched normal subjects. Psychoneuroendocrinol. 1988; 13: 497-503.
19. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, revised. American Psychiatric Association, Washington, DC, 1987.
20. Stokes PE, Stoll PM, Mattson MR, Sullod RW. Diagnosis and psychopathology in psychiatric patients resistant to dexamethasone. In: Sachar EJ (ed.). Hormones, Behavior, and Psychopathology. Raven Press, New York, 1976; 225-229.
21. Carroll BJ, Feinberg M, Greden JF. A specific laboratory test for the diagnosis of melancholia: Standardization, validation and clinical utility. Arch. Gen. Psychiatry 1981; 38: 15-22.
22. Nelson JC, Davis JM. DST studies in psychiatric depression: A meta-analysis. Am. J. Psychiatry 1997; 154: 1497-1503.
23. Greden JF, Gardner R, King D. Dexamethasone suppression test in antidepressant treatment of melancholia: The process of normalization and test-retest reproducibility. Arch. Gen. Psychiatry 1983; 40: 493-500.
24. Drateu L, Calil HM. The dexamethasone suppression test: Its relationship to diagnoses, severity of depression and response to treatment. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 1989; 13: 99-117.
25. Coryell WH, Zimmerman M. HPA axis hyperactivity and recovery from functional psychoses. Am. J. Psychiatry 1989; 146: 473-477.
26. Ribeiro SC, Tandon R, Grunbaus L, Greden JF. The DST as a predictor of outcome in depression: A meta-analysis. Am. J. Psychiatry 1993; 150: 1618-1629.
27. Hunt GE, O'Sullivan BT, Johnson GF, Gaterson ID. Effect of high plasma dexamethasone levels on DST sensitivity: Dose-response study in depressed patients and controls. Psychiatry Res. 1991; 36: 209-222.
28. Mossman D, Somoza E. Do serum dexamethasone levels improve the DST? J. Affect. Dis. 1990; 20: 13-18.
29. Wiedemann K, Holsboer F. The effect of dexamethasone dosage upon plasma cortisol and dexamethasone during the DST. J. Affect. Dis. 1990; 19: 133-137.
30. O'Sullivan BT, Cutler DJ, Hunt GE, Walters C, Johnson GF, Caterson ID. Pharmacokinetics of dexamethasone and its relationship to dexamethasone suppression test outcome in depressed patients and healthy control subjects. Biol. Psychiatry 1997; 41: 574-584.
31. Graybeal ML, Fang VS. Physiological dosing of exogenous ACTH. Acta Endocrinol. 1985; 108: 401-406.
32. Fang VS, Jiang HK, Rose RP, Luchins DJ. Adrenal gland in major depression: Enlarged capacity or enhanced sensitivity? Arch. Gen. Psychiatry 1988; 45: 964-966.
33. Sherman B, Pfohl B, Winokur G. Circadian analysis of plasma Cortisol levels before and after dexamethasone administration in depressed patients. Arch. Gen. Psychiatry 1984; 41: 211-215.
34. Kalin NH, Dawson G. Neuroendocrine dysfunction in depression: Hypothalamic-anterior pituitary systems. Trends Neurol. Sci. 1986; 9: 261-266.
35. Shimoda K, Yamada N, Hanada K, Tsujimoto T, Takahashi S, Takahashi K. Morning and evening adrenocortical responses to ACTH stimulation in endogenously depressed patients: A preliminary report. Jpn. J. Psychiatry Neurol. 1989; 43: 57-62.
36. Alsever RN, Gotlin RW. Cosyntropin stimulation test. In: Alsever RN (ed.). Handbook of Endocrine Tests in Adults and Children. Year Book Medical Publishers, Chicago, 1978; 73-95.